- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06458101
Efficacy and Safety of Ureteroscopic Lithotripsy (Including Flexible Ureteroscopy) Without Indwelling Urinary Catheter
November 17, 2025 updated by: Yi Shao, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Efficacy and Safety of Ureteroscopic Lithotripsy (Including Flexible Ureteroscopy) Without Indwelling Urinary Catheter: a Multicenter, Randomized, Controlled Study
A prospective, multicenter, randomized, controlled clinical trial was conducted to compare the efficacy and safety of non-indwelling catheter and indwelling catheter in relieving postoperative catheter-related complications after ureteroscopic lithotripsy.
By comparing the pain score and urination urgency score (PPIUS) of patients after ureteroscopic lithotripsy (including flexible ureteroscopy) lithotripsy to provide a reliable scientific basis for indwelling catheter after ureteroscopic lithotripsy.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
180
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, China, 200080
- Shanghai General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients with upper urinary tract calculi undergoing rigid ureteroscopic and soft ureteroscopic lithotripsy;
- Normal renal function;
- Aged between 18 and 70 years old
- Complete the operation under general anesthesia
Exclusion Criteria:
- Solitary kidney;
- Previous history of renal transplantation or urinary diversion;
- Congenital malformation of urinary system;
- Abnormal coagulation mechanism due to blood system diseases, liver diseases, etc.
- Severe heart or lung disease, Malignant tumor and immunodeficiency state
- Urethral stricture
- Neurogenic bladder
- Operation under epidural anesthesia or spinal anesthesia
- Large amount of bleeding during operation should be observed by indwelling catheter to observe urine color
- High risk factors such as large amount of pus fur should be observed during operation.
- Urethral injury during operation leads to false passage
- Operation time is more than 90 minutes. Higher risk of bleeding or infection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Group 1: Ureteroscopy (including flexible endoscope) lithotripsy with indwelling urinary catheter
Ureteroscopy (including flexible endoscope) lithotripsy with indwelling urinary catheter
|
Ureteroscopy (including flexible endoscope) lithotripsy with indwelling urinary catheter
|
|
Experimental: Group 2: Ureteroscopy (including flexible endoscope) lithotripsy without indwelling urinary catheter
Ureteroscopy (including flexible endoscope) lithotripsy without indwelling urinary catheter
|
Ureteroscopy (including flexible endoscope) lithotripsy without indwelling urinary catheter
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain score
Time Frame: 4 hours after surgery and 2 hours after catheter removal (same time points for non-indwelling catheters)
|
pain scoring will be measured by VAS scale.
There are 10 scales, with "0" and "10" at both ends.
0 indicates no pain and 10 represents the most severe pain that is unbearable.
|
4 hours after surgery and 2 hours after catheter removal (same time points for non-indwelling catheters)
|
|
Urinary urgency score
Time Frame: 4 hours after surgery and 2 hours after catheter removal (same time points for non-indwelling catheters)
|
urinary urgency score will be measured by PPIUS scale. 0 No urgency
|
4 hours after surgery and 2 hours after catheter removal (same time points for non-indwelling catheters)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Painful Memory
Time Frame: 1 month after surgery
|
Painful memory will be measured by SUDS scale.
100: Unbearably upset to the point that you cannot function and may be on the verge of a breakdown 90: Extremely anxious and desperate; helpless and unable to handle it 80: Worried and panicky; losing focus and feeling anxious in your body 70: Discomfort dominates your thoughts and you struggle to function normally 60: Moderate to strong levels of discomfort 50: Upset and uncomfortable; still functional 40: Mild to moderate anxiety and worry 30: Worried or upset; still able to function 20: A little bit sad or distressed 10: No distress; alert and focused 0: Peaceful and complete calm
|
1 month after surgery
|
|
Operation time
Time Frame: The end of operation
|
Operation time
|
The end of operation
|
|
blood routine
Time Frame: Before surgery and 4 hours after surgery
|
To calculate the change of haemoglobin
|
Before surgery and 4 hours after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2024
Primary Completion (Actual)
June 30, 2025
Study Completion (Actual)
June 30, 2025
Study Registration Dates
First Submitted
June 3, 2024
First Submitted That Met QC Criteria
June 9, 2024
First Posted (Actual)
June 13, 2024
Study Record Updates
Last Update Posted (Actual)
November 19, 2025
Last Update Submitted That Met QC Criteria
November 17, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Urogenital Diseases
- Male Urogenital Diseases
- Urologic Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urolithiasis
- Therapeutics
- Diagnostic Techniques and Procedures
- Diagnosis
- Surgical Procedures, Operative
- Minimally Invasive Surgical Procedures
- Diagnostic Techniques, Surgical
- Endoscopy
- Urologic Surgical Procedures
- Urogenital Surgical Procedures
- Diagnostic Techniques, Urological
- Ultrasonic Surgical Procedures
- Ureteroscopy
- Lithotripsy
Other Study ID Numbers
- IIT2024-050
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
After the trial is completed, it is shared on the network platform: China Clinical trial Registration Center; website: http://www.chictr.org.cn
IPD Sharing Time Frame
After the trial is completed,
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urolithiasis
-
Beni-Suef UniversityRecruiting
-
Singapore General HospitalUnknown
-
Kırıkkale UniversityCompletedKidney Calculi Nephrolithiasis Urolithiasis Renal Stone
-
University of Sao Paulo General HospitalCompletedUrolithiasis and Aging | Renal Calcul and Metabolic Diseases | Urolithiasis and OsteoporosisBrazil
-
EULIS Colloborative Research Working GroupUnknownKidney Calculi | Nephrolithiasis | Patient Compliance | Calcium Oxalate Urolithiasis
-
Catalysis SLCompletedKidney Calculi | Kidney Injury | Urolithiasis | Ureteral Calculi | Ureteral Obstruction | Renal Disease | Renal Stone | Ureteral Injury | Renal Injury | Urolithiasis, Calcium Oxalate | Urolithiasis; Lower Urinary TractNicaragua
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...RecruitingHealthy | Kidney Calculi | Nephrolithiasis | Urolithiasis | Kidney Stone | Nephrolithiasis, Calcium Oxalate | Oxaluria | Urolithiasis, Calcium Oxalate | Oxalate UrolithiasisUnited States
-
London Health Sciences Centre Research Institute...St. Joseph's Health Care LondonCompletedKidney Calculi | Nephrolithiasis | Kidney Stone | Human | Calcium Oxalate Urolithiasis | Vitamin K 2 | Calcium Oxalate Kidney Stones | Calcium Phosphate UrolithiasisCanada
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...RecruitingHealthy | Kidney Calculi | Nephrolithiasis | Urolithiasis | Healthy Volunteer | Kidney Stones | Nephrolithiasis, Calcium Oxalate | Urolithiasis, Calcium Oxalate | Oxalate UrolithiasisUnited States
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...RecruitingKidney Calculi | Nephrolithiasis | Urolithiasis | Kidney Stone | Nephrolithiasis, Calcium Oxalate | Oxaluria | Urolithiasis, Calcium Oxalate | Oxalate UrolithiasisUnited States
Clinical Trials on Ureteroscopy (including flexible endoscope) lithotripsy with indwelling urinary catheter
-
University of Massachusetts, WorcesterCompletedUrinary Retention | Bladder Dysfunction